Zach Collins

Zach Collins is a Boston, Massachusetts-based biotechnology entrepreneur and life sciences investor focused on translating complex scientific discoveries into viable clinical therapeutics for patients. He earned his PhD in Biological and Biomedical Sciences from Harvard Medical School, establishing a rigorous technical foundation that informs his current approach to early-stage drug discovery and venture development. Operating at the intersection of academia and commercial industry, Collins has built a career around founding and scaling specialized biotech startups that target significant unmet medical needs globally. His professional background combines deep scientific research with strategic enterprise building, allowing him to evaluate and advance novel treatment modalities from the laboratory into the broader healthcare market. Ultimately, Collins leverages his advanced academic credentials and prior startup experience to focus on therapeutics development, actively driving the commercialization of next-generation biotechnology innovations.